US Stock MarketDetailed Quotes

ORIC Oric Pharmaceuticals

Watchlist

8.250
-0.100-1.20%

Close Dec 27 16:00 ET

8.250
0.0000.00%

Post 16:00 ET

582.18MMarket Cap-4.53P/E (TTM)

Oric Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oric Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Oric Pharmaceuticals Earnings Reports

Oric Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12 16:27 ET

Oric Pharmaceuticals | 8-K: ORIC ® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates

Nov 12 16:16 ET

Oric Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 12 16:21 ET

Oric Pharmaceuticals | 8-K: ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates

Aug 12 16:12 ET

Analyst Rating

Updated: Dec 10, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall